Tree-based machine learning nominates Parabacteroides merdae and N-acetyl-D-mannosamine as ulcerative-colitis alleviators in a mouse model
The researchers combined personalized gut-microbiome community metabolic models from human iHMP data with tree-based machine-learning feature selection to identify microbial strains and metabolites associated with ulcerative-colitis samples. Parabacteroides merdae ATCC 43,184 and N-acetyl-D-mannosamine were among the most predictive features; the strain was also the main modeled microbial contributor to the metabolite. In a DSS-induced mouse colitis experiment, oral administration of the bacterium or metabolite improved reported colitis measures.
Technology: Tree-based supervised classifiers including random forest, gradient-boosted regression trees, XGBoost, XGBoost-random forest and LightGBM, combined with individualized genome-scale microbiome community models
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: In a DSS-induced mouse colitis experiment, oral administration of the bacterium or metabolite improved reported colitis measures.
- Still unknown: The human data are observational microbiome samples, while intervention was tested in a DSS-induced mouse model, not in people. The animal groups contained eight mice each; findings do not establish treatment efficacy or safety in human ulcerative colitis. Metabolite-production associations came from community-model simulations and were not direct evidence of individual strain production in each person. The model provides candidate prioritization, not a causal human mechanism.
- AI role: Personalized community metabolic models estimated strain-level contributions to secreted metabolites in human iHMP samples. Tree-based classifiers selected discriminative strain and metabolite features; XGBRF feature attribution ranked P. merdae ATCC 43,184 and N-acetyl-D-mannosamine highly, motivating the mouse validation. The AI analysis nominated these targets; it did not establish human therapeutic efficacy.
Evidence sources: https://www.tandfonline.com/doi/full/10.1080/19490976.2024.2336877
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: at percentile 88 of works of the same type, year and subfield (OpenAlex work metrics, 19 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.